Chairman becomes major investor in company that wants to prevent Alzheimer's disease using light therapy

The Danish-US company Optoceutics has gained a large investment from board chairman Rasmus Just, who is now considered a major investor in the company, which is attempting to prevent Alzheimer's disease using light therapy.

Rasmus Just, chairman of Optoceutics, has increased his share in the company, which wants to discover a cure for Alzheimer's disease. Photo: Rasmus Just/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles